Evidence map›Paper›PMID 33608403›Full record

Trial reportBMJ open2021

Quality of life among adult patients living with diabetes in Rwanda: a cross-sectional study in outpatient clinics.

Charilaos Lygidakis, Jean Paul Uwizihiwe, Michela Bia, Francois Uwinkindi, Per Kallestrup, Claus Vögele

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03376607 (Community- and mHealth-Based Integrated Management of Diabetes in Primary Healthcare in Rwanda), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03376607 naunknown statusnot on this map

Community- and mHealth-Based Integrated Management of Diabetes in Primary Healthcare in Rwanda: The D²Rwanda Study

TypeinterventionalSponsorUniversity of AarhusRan2019 to 2021Enrolled209ConditionsDiabetes Mellitus, Telemedicine, Community Health WorkersArmsHBCP programme, mobile health application
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

Charilaos LygidakisDepartment of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg lygidakis@gmail.com.ORCID 0000-0003-2571-6286
Jean Paul UwizihiweCollege of Medicine and Health Sciences, University of Rwanda, Butare, Rwanda.
Michela BiaLuxembourg Institute of Socio-Economic Research (LISER), Esch-sur-Alzette, Luxembourg.
Francois UwinkindiDivision of Non Communicable Diseases, Rwanda Biomedical Center (RBC), Kigali, Rwanda.
Per KallestrupCentre for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.
Claus VögeleDepartment of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Aarhus University · DKUniversity of Luxembourg · LULuxembourg Institute of Socio-Economic Research · LURwanda Biomedical Center · RW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo report on the disease-related quality of life of patients living with diabetes mellitus in Rwanda and identify its predictors.

designCross-sectional study, part of the baseline assessment of a cluster-randomised controlled trial.

settingOutpatient clinics for non-communicable diseases of nine hospitals across Rwanda.

participantsBetween January and August 2019, 206 patients were recruited as part of the clinical trial. Eligible participants were those aged 21-80 years and with a diagnosis of diabetes mellitus for at least 6 months. Illiterate patients, those with severe hearing or visual impairments, those with severe mental health conditions, terminally ill, and those pregnant or in the postpartum period were excluded PRIMARY AND SECONDARY OUTCOME MEASURES: Disease-specific quality of life was measured with the Kinyarwanda version of the Diabetes-39 (D-39) questionnaire. A glycated haemoglobin (HbA1c) test was performed on all patients. Sociodemographic and clinical data were collected, including medical history, disease-related complications and comorbidities.

resultsThe worst affected dimensions of the D-39 were 'anxiety and worry' (mean=51.63, SD=25.51), 'sexual functioning' (mean=44.58, SD=37.02), and 'energy and mobility' (mean=42.71, SD=20.69). Duration of the disease and HbA1c values were not correlated with any of the D-39 dimensions. A moderating effect was identified between use of insulin and achieving a target HbA1c of 7% in the 'diabetes control' scale. The most frequent comorbidity was hypertension (49.0% of participants), which had a greater negative effect on the 'diabetes control' and 'social burden' scales in women. Higher education was a predictor of less impact on the 'social burden' and 'energy and mobility' scales.

conclusionsSeveral variables were identified as predictors for the five dimensions of quality of life that were studied, providing opportunities for tailored preventive programmes. Further prospective studies are needed to determine causal relationships. TRIAL REGISTRATION NUMBER: NCT03376607.

Indexed as

Diabetes MellitusQuality of LifeAdultAgedAged, 80 and overAmbulatory Care FacilitiesCross-Sectional StudiesFemaleGlycated HemoglobinHumansMiddle AgedProspective StudiesRwandaYoung AdultGlycated Hemoglobingeneral diabetesprimary carepublic health

Identifiers

PMID33608403
PMCPMC7896598
OpenAlexW3130385067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.